<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01272882</url>
  </required_header>
  <id_info>
    <org_study_id>CCC#30067</org_study_id>
    <secondary_id>DDD# 600788</secondary_id>
    <nct_id>NCT01272882</nct_id>
  </id_info>
  <brief_title>Electrical Impedance Tomography (EIT) Monitoring in Adults With ALI or ARDS</brief_title>
  <official_title>Electrical Impedance Tomography (EIT) Monitoring: A Pilot Comparison to Standard of Care Assessments in Adults With Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Christiana Care Health Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Christiana Care Health Services</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Electrical impedance tomography (EIT) monitoring has been researched as a method to determine
      the spatial impedance distribution in a body cross section, but has yet to become an
      established clinical tool. EIT monitoring gives a dynamic, breath-to-breath measurement of
      both global and regional ventilation. Recently, there has been evidence that EIT monitoring
      has great potential to become a non-invasive bedside tool for assessment of regional lung
      ventilation without documented hazards. Potential applications include any adult patients in
      acute respiratory failure. Data collected from this research may contribute to improved
      patient safety outcomes.

      PURPOSE:

      The purpose of this pilot study is to examine the feasibility of using the EIT monitor in
      intensive care unit (ICU) setting on patients with acute respiratory failure and to compare
      the EIT monitor data to standard of care patient assessments. It is hypothesized that the EIT
      monitor, when applied to adults in acute respiratory failure, will correlate with
      conventional standard of care assessments for these patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      INTRODUCTION:

      Electrical impedance tomography (EIT) monitoring has been researched as a method to determine
      the spatial impedance distribution in a body cross section, but has yet to become an
      established clinical tool. EIT monitoring gives a dynamic, breath-to-breath measurement of
      both global and regional ventilation. Recently, there has been evidence that EIT monitoring
      has great potential to become a non-invasive bedside tool for assessment of regional lung
      ventilation without documented hazards. Potential applications include any adult patients in
      acute respiratory failure. Data collected from this research may contribute to improved
      patient safety outcomes.

      PURPOSE:

      The purpose of this pilot study is to examine the feasibility of using the EIT monitor in ICU
      setting on patients with acute respiratory failure and to compare the EIT monitor data to
      standard of care patient assessments. It is hypothesized that the EIT monitor, when applied
      to adults in acute respiratory failure, will correlate with conventional standard of care
      assessments for these patients.

      METHOD:

      This pilot study design will consist of a prospective, blinded evaluation of the EIT monitor
      for patients with acute lung injury or acute respiratory distress syndrome.

      Once a patient has met the inclusion criteria and has signed informed consent:

        1. EIT electrode chest band will be applied by trained respiratory care staff. Application
           includes elastic chest band with 16 electrodes.

        2. EIT electrode chest band is connected to the EIT monitor which will be turned on and
           will monitor and store EIT data.

        3. EIT monitoring will take place for 4 to 6 hours, during day shift (7am to 4pm)

        4. Patient's may be monitored on three separate days.

      No interventions, tests or modifications to the standard of care will occur to patients for
      this pilot study of EIT monitoring. Clinicians guiding the care of these patients will be
      blinded to the EIT data. The EIT chest band will be removed if transport of the patient is
      necessary or if care is needed in the area of the chest band.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of EIT Monitoring in This Population of ARDS/ALI Patients</measure>
    <time_frame>At the start of monitoring once the patient was consented and enrolled.</time_frame>
    <description>Feasibility for the purposes of our study was the ability to apply the device to a diverse population of ARDS/ALI patients and obtain EIT data from the device.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Acute Lung Injury (ALI)</condition>
  <condition>ARDS</condition>
  <arm_group>
    <arm_group_label>Adults with ARDS or ALI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adults with PaO2/FiO2 ratio less than 300. Consented patients will be placed on EIT monitor. The only intervention is the addition of Electrical Impedance Tomography monitoring using the Chest belt with 16 electrodes connected to the EIT device. No changes to standard patient care will occur other than collecting EIT monitor data.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electrical Impedance Tomography monitoring</intervention_name>
    <description>Chest belt with 16 electrodes connected to the EIT device</description>
    <arm_group_label>Adults with ARDS or ALI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients will be included in this study if the following criteria have been met:

          1. Males and females &gt; 18 years old (non−pregnant, non−lactating females).

          2. Partial pressure of arterial oxygen (PaO2) / Fraction of inspired oxygen (FiO2) ratio
             &lt; 300 torr.

          3. Signed informed consent has been obtained.

        Exclusion Criteria:

          1. Females who are pregnant or lactating.

          2. Patients with skin abrasions or wounds in the chest area.

          3. Patients receiving dialysis.

          4. Patients with pacemakers or paced EKG rhythms.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John S Emberger, BS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Christiana Care Health Services</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vinay Maheshwari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Christiana Care Health Services</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joel M Brown, BS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Christiana Care Health Services</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Christiana Hospital</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19718</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2011</study_first_submitted>
  <study_first_submitted_qc>January 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2011</study_first_posted>
  <results_first_submitted>October 31, 2012</results_first_submitted>
  <results_first_submitted_qc>December 4, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 7, 2013</results_first_posted>
  <last_update_submitted>April 27, 2017</last_update_submitted>
  <last_update_submitted_qc>April 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Lung Injury</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD data will not be shared</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Intensive care units</recruitment_details>
      <pre_assignment_details>No pre-assignment details to note.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Adults With ARDS or ALI</title>
          <description>Adults with PaO2/FiO2 ratio less than 300.
Electrical Impedance Tomography monitoring : Chest belt with 16 electrodes connected to the EIT device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Adults With ARDS or ALI</title>
          <description>Adults with PaO2/FiO2 ratio less than 300.
Electrical Impedance Tomography monitoring : Chest belt with 16 electrodes connected to the EIT device</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55" spread="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Feasibility of EIT Monitoring in This Population of ARDS/ALI Patients</title>
        <description>Feasibility for the purposes of our study was the ability to apply the device to a diverse population of ARDS/ALI patients and obtain EIT data from the device.</description>
        <time_frame>At the start of monitoring once the patient was consented and enrolled.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adults With ARDS or ALI</title>
            <description>Adults with PaO2/FiO2 ratio less than 300. Electrical Impedance Tomography monitoring : Chest belt with 16 electrodes connected to the EIT device</description>
          </group>
        </group_list>
        <measure>
          <title>Feasibility of EIT Monitoring in This Population of ARDS/ALI Patients</title>
          <description>Feasibility for the purposes of our study was the ability to apply the device to a diverse population of ARDS/ALI patients and obtain EIT data from the device.</description>
          <units>Patients successfully monitored with EIT</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Adults With ARDS or ALI</title>
          <description>Adults with PaO2/FiO2 ratio less than 300.
Electrical Impedance Tomography monitoring : Chest belt with 16 electrodes connected to the EIT device</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Gerard Fulda</name_or_title>
      <organization>ChristianaCHS</organization>
      <phone>302-733-4260</phone>
      <email>gfulda@christianacare.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

